IRUZID
Tablet, 10mg + 12.5mg
RxActive license
Active substance (INN)
hydrochlorothiazidelisinopril
Pharmaceutical form
Pharmaceutical formTablet
Strength10mg + 12.5mg
PackagingUkupno 30 tableta u blisteru (1x30) u kartonskoj kutiji
Manufacturerlijekovi i kozmetika d.d., Croatia
Therapeutic groupCardiovascular system (C09BA03)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateJuly 8, 2024
Analogs in Montenegro
20Other medicines with the same active substance
AMPRIL HDRx
Tablet, 5mg + 25mgAMPRIL HLRx
Tablet, 2.5mg + 12.5mgCO-DIOVANRx
Film-coated tablet, 80mg + 12.5mgENAP-HRx
Tablet, 10mg + 25mgFLIRKANORx
Film-coated tablet, 160mg + 5mg + 12.5mgFLIRKANORx
Film-coated tablet, 160mg + 10mg + 12.5mgFLIRKANORx
Film-coated tablet, 320mg + 10mg + 25mgFLIRKANORx
Film-coated tablet, 160mg + 5mg + 25mgFLIRKANORx
Film-coated tablet, 160mg + 10mg + 25mgIRBENIDA PLUSRx
Film-coated tablet, 150mg/12.5mgIRBENIDA PLUSRx
Film-coated tablet, 300mg/12.5mgIRUMED®Rx
Tablet, 10mgIRUMED®Rx
Tablet, 20mgIRUZIDRx
Tablet, 20mg + 12.5mgLISONORMRx
Tablet, 10mg + 5mgLODOZRx
Film-coated tablet, 5mg + 6.25mgLODOZRx
Film-coated tablet, 2.5mg + 6.25mgLODOZRx
Film-coated tablet, 10mg + 6.25mgLOPRILRx
Tablet, 10mgLOPRILRx
Tablet, 20mgSource: CInMED register